> top > docs > PubMed:10024875 > annotations

PubMed:10024875 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-gro-2013-development

Id Subject Object Predicate Lexical cue
T1 23-32 CellComponent denotes lysosomal
T2 33-41 Protein denotes proteins
T5 95-110 ProteinSubunit denotes beta 3A subunit
T6 118-130 Protein denotes AP-3 adaptor
T9 213-221 CellComponent denotes lysosome
T10 230-240 CellComponent denotes organelles
T13 319-334 ProteinSubunit denotes beta 3A subunit
T14 342-371 Protein denotes heterotetrameric AP-3 complex
T15 387-398 Cell denotes fibroblasts
T17 437-441 Protein denotes AP-3
T20 480-487 ProteinSubunit denotes beta 3A
T21 493-497 Protein denotes AP-3
T26 584-588 Protein denotes CD63
T27 590-596 Protein denotes lamp-1
T28 602-608 Protein denotes lamp-2
T31 727-731 Protein denotes AP-3
T32 732-745 ProteinSubunit denotes mu 3A subunit
T34 786-795 CellComponent denotes lysosomal
T36 832-836 Protein denotes AP-3
T39 869-878 CellComponent denotes lysosomes
T40 907-912 Eukaryote denotes human
T24 556-583 Protein denotes lysosomal membrane proteins
T25 621-642 Protein denotes nonlysosomal proteins
T38 953-979 Protein denotes integral membrane proteins
E1 45-70 Disease denotes Hermansky-Pudlak syndrome
E2 78-87 Mutation denotes mutations
E3 132-157 Disease denotes Hermansky-Pudlak syndrome
E4 159-162 Disease denotes HPS
E5 284-287 Disease denotes HPS
E6 302-311 Mutation denotes mutations
E7 419-426 Decrease denotes reduced
E8 449-457 Increase denotes enhanced
E9 458-469 ProteinCatabolism denotes degradation
E10 520-529 PositiveRegulation denotes increased
E11 538-548 GeneExpression denotes expression
E13 796-805 ProteinTargeting denotes targeting
E15 913-920 Disease denotes disease
E16 990-999 Mutation denotes mutations
E17 498-508 Decrease denotes deficiency
E12 751-773 SignalingPathway denotes tyrosine-based signals
E18 708-719 MolecularInteraction denotes interaction
E14 850-865 ProteinTransport denotes protein sorting
E19 938-949 ProteinTransport denotes trafficking
E20 930-937 Affecting denotes altered
E21 1022-1039 ProteinTransport denotes sorting machinery
E22 708-719 MolecularInteraction denotes interaction
E23 538-548 GeneExpression denotes expression
E24 538-548 GeneExpression denotes expression
E25 520-529 PositiveRegulation denotes increased
E26 520-529 PositiveRegulation denotes increased
R1 T2 T1 locatedIn proteins,lysosomal
R2 T6 T5 hasPart AP-3 adaptor,beta 3A subunit
R3 T14 T13 hasPart heterotetrameric AP-3 complex,beta 3A subunit
R4 E7 T15 locatedIn reduced,fibroblasts
R7 T31 T32 hasPart AP-3,mu 3A subunit
R8 E15 T40 fromSpecies disease,human
R10 T5 E2 hasPatient beta 3A subunit,mutations
R11 T13 E6 hasPatient beta 3A subunit,mutations
R12 E8 E7 hasAgent enhanced,reduced
R13 T17 E7 hasPatient AP-3,reduced
R14 E9 E8 hasPatient degradation,enhanced
R15 T20 E9 hasPatient beta 3A,degradation
R16 E17 E10 hasAgent deficiency,increased
R17 E11 E10 hasPatient expression,increased
R18 T26 E11 hasPatient CD63,expression
R19 E20 E16 hasAgent altered,mutations
R20 E21 E16 hasPatient sorting machinery,mutations
R21 T21 E17 hasPatient AP-3,deficiency
R22 T32 E18 hasPatient mu 3A subunit,interaction
R23 T36 E14 hasAgent AP-3,protein sorting
R24 T38 E19 hasPatient integral membrane proteins,trafficking
R25 E19 E20 hasPatient trafficking,altered
R26 E12 E22 hasPatient tyrosine-based signals,interaction
R27 T27 E23 hasPatient lamp-1,expression
R28 T28 E24 hasPatient lamp-2,expression
R29 E17 E25 hasAgent deficiency,increased
R30 E23 E25 hasPatient expression,increased
R31 E17 E26 hasAgent deficiency,increased
R32 E24 E26 hasPatient expression,increased